Moexipril
From Wikipedia, the free encyclopedia
| This article does not cite any references or sources. (April 2008) Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed. |
|
Moexipril
|
|
| Systematic (IUPAC) name | |
| (3S)-2-[(2S)-2-[ [(2S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid | |
| Identifiers | |
| CAS number | |
| ATC code | C09 |
| PubChem | |
| Chemical data | |
| Formula | C27H34N2O7 |
| Mol. mass | 498.568 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
D(US) |
| Legal status | |
| Routes | Oral |
Moexipril (marketed under the tradenames Univasc and Perdix) is an ACE inhibitor.
|
|||||||||||

